Skip to Main Content

Paper Details

OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer.
Sci Rep
6
2022
-, -target neural gene, AR, AR-negative PC, AR-negative PC cells, Androgen, OCT1, PC, PFN2, SNTB1, STNB1, androgen, androgen receptor, androgen receptor-negative prostate cancer, castration, castration-resistant AR-negative PC cells, genes, human, human AR-negative PC tissues, neural genes, neural precursor cell, patient, patients, prostate cancer, target genes, tumor, tumors
Author NameAffiliation
Makoto R HaraNihon University School of Medicine
Mitchell G LawrenceMonash Biomedicine Discovery Institute Cancer Program, Monash University
Mitchell G LawrencePeter MacCallum Cancer Centre
Mitchell G LawrenceThe University of Melbourne
Mitchell G LawrenceMonash Biomedicine Discovery Institute Cancer Program, Monash University
Mitchell G LawrenceCabrini Institute
Renea A TaylorPeter MacCallum Cancer Centre
Renea A TaylorThe University of Melbourne
Renea A TaylorMonash Biomedicine Discovery Institute Cancer Program, Monash University
Renea A TaylorCabrini Institute
Renea A TaylorMonash Biomedicine Discovery Institute Cancer Program, Monash University
Gail P RisbridgerMonash Biomedicine Discovery Institute Cancer Program, Monash University
Gail P RisbridgerPeter MacCallum Cancer Centre
Gail P RisbridgerThe University of Melbourne
Gail P RisbridgerMonash Biomedicine Discovery Institute Cancer Program, Monash University
Gail P RisbridgerCabrini Institute
  • 1 - 16

Datasets

Release 1.2